Ginsenoside Rh2 sensitizes the anti-cancer effects of sunitinib by inducing cell cycle arrest in renal cell carcinoma

Sunitinib, a VEGF blockade, is used to treat clear cell renal cell carcinoma (ccRCC). However, the anti-cancer treatment effects of sunitinib do not last long in ccRCC patients. Ginsenoside, a natural medicine extracted from ginseng, has been studied in cancer treatment and shown to have anti-tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Hyun Ji, Hong, Seong Hwi, Moon, Hong Sang, Yoon, Young Eun, Park, Sung Yul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672391/
https://www.ncbi.nlm.nih.gov/pubmed/36396667
http://dx.doi.org/10.1038/s41598-022-20075-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672391/
https://www.ncbi.nlm.nih.gov/pubmed/36396667
http://dx.doi.org/10.1038/s41598-022-20075-0

Ejemplares similares